<!DOCTYPE html>
<html>
<style type="text/css">
    /* all in one */
    /* 初始化钢琴动画 */

    @keyframes piano-init {}

    @-webkit-keyframes piano-init {}

    /* 钢琴键激活 */

    @keyframes key-activate {
        0% {
            width: 100%;
            height: 2rem;
        }

        100% {
            width: 150%;
            height: 3rem;
        }
    }

    @-webkit-keyframes key-activate {
        0% {
            width: 100%;
            height: 100%;
        }

        100% {
            width: 150%;
            height: 150%;
        }
    }

    @keyframes key-kernel-activate {
        0% {
            background-color: rgb(186, 186, 186);
        }

        100% {
            background-color: rgb(255, 55, 68);
        }
    }

    @-webkit-keyframes key-kernel-activate {
        0% {
            background-color: rgb(255, 55, 68);
        }

        100% {
            background-color: rgb(186, 186, 186);
        }
    }

    /* 钢琴键取消激活 */

    @keyframes key-deactivate {
        0% {
            background-color: rgb(255, 55, 68);
        }

        100% {
            background-color: rgb(186, 186, 186);
        }
    }

    @-webkit-keyframes key-deactivate {}

    /* 钢琴键内部字体淡入 */

    @keyframes key-title-in {}

    @-webkit-keyframes key-title-in {}

    /* 钢琴内部字体淡出 */

    @keyframes key-title-out {}

    @-webkit-keyframes key-title-out {}

    /* 鼠标悬停在content */

    @keyframes content-hover-2item {
        0% {
            width: 50%;
        }

        100% {
            width: 40%;
        }
    }

    @-webkit-keyframes content-hover-2item {
        0% {
            width: 50%;
        }

        100% {
            width: 40%;
        }
    }

    /* @keyframes {}
@-webkit-keyframes{} */

    .piano-subpage {
        background-color: rgba(0, 0, 0, 0);
        position: fixed;
        z-index: 200;
        float: left;
        top: 20rem;
        display: flex;
        flex-direction: column;
        justify-content: flex-start;
    }

    /* demo继承的子类piano */

    .piano-subpage-demo {
        width: 16rem;
        /* height: 44rem; */
    }

    .piano-subpage-key {
        /* margin: 1rem 0rem 1rem 0; */
        width: 8vw;
        height: 1vh;
        background-color: rgba(0, 0, 0, 0);
        /*  */
        animation-name: key-activate;
        -webkit-animation-name: key-activate;
    }

    .animation {
        animation-duration: 0.4s;
        animation-timing-function: ease;
        animation-fill-mode: forwards;
        -webkit-animation-duration: 0.4s;
        -webkit-animation-timing-function: ease;
        -webkit-animation-fill-mode: forwards;
    }

    .piano-subpage .key-kernel {
        /* background-color: rgb(255,55,68); */
        background-color: rgb(186, 186, 186);
        height: 100%;
        border-radius: 0rem 0.3rem 0.3rem 0rem;
        -moz-border-radius: 0.3rem;
        /* Old Firefox */
        box-shadow: 0.4rem 0.4rem 0.2rem rgba(180, 180, 180, 50%);
        /*  */
        animation-name: key-kernel-activate;
        -webkit-animation-name: key-kernel-activate;
        animation-play-state: running;
        -webkit-animation-play-state: running;
    }

    .key-kernel-0 {
        width: 80%;
    }

    .key-kernel-1 {
        width: 85;
    }

    .key-kernel-2 {
        width: 50%;
    }

    .key-kernel-3 {
        width: 62%;
    }

    .key-kernel-4 {
        width: 90%;
    }

    .key-kernel-5 {
        width: 48%;
    }

    /* 下面是页面内容css */

    .sub-content {
        width: 90vw;
        /* background-color: rgb(186,186,186); */
        margin: 0 5vw 0 5vw;
    }

    .switch {
        background-color: brown;
        opacity: 0;
        position: absolute;
        height: inherit;
        width: inherit;
        float: left;
        z-index: 10;
    }

    .mask-0,
    .mask-1,
    .mask-2,
    .mask-3,
    .mask-4 {
        /* Safari for macOS & iOS */
        -webkit-backdrop-filter: blur(5px);
        /* Google Chrome */
        backdrop-filter: blur(5px);
    }

    .m00,
    .m10,
    .m13,
    .m21,
    .m30,
    .m32,
    .m40,
    .m42 {
        background-color: rgb(25, 46, 67, 0.7) !important;
    }

    .m01,
    .m11,
    .m12,
    .m20,
    .m31,
    .m41 {
        background-color: rgba(255, 55, 68, 0.7) !important;
    }

    .mask-front-content-box {
        position: absolute;
        height: inherit;
        width: inherit;
        float: left;
        z-index: 9;
        display: flex;
        flex-wrap: wrap;
    }

    .mask-front-content-10,
    .mask-front-content-11,
    .mask-front-content-12,
    .mask-front-content-13 {
        width: 50%;
        height: 50%;
    }

    .mask-front-content-10>p,
    .mask-front-content-11>p,
    .mask-front-content-12>p,
    .mask-front-content-13>p {
        font-size: 2vw !important;
    }

    .mask-front-content-00,
    .mask-front-content-01 {
        width: 50%;
        height: initial;
    }

    .mask-front-content-00>p,
    .mask-front-content-01>p {
        font-size: 6vw !important;
    }

    .mask-front-content-20,
    .mask-front-content-21 {
        width: 50%;
        height: initial;
    }

    .mask-front-content-20>p,
    .mask-front-content-21>p {
        font-size: 3.5vw !important;
    }

    .mask-front-content-30,
    .mask-front-content-31,
    .mask-front-content-32 {
        width: 100%;
        height: 50%;
    }

    .mask-front-content-40,
    .mask-front-content-41,
    .mask-front-content-42 {
        width: 100%;
        height: 50%;
    }

    .mask-front-content-40>p,
    .mask-front-content-41>p,
    .mask-front-content-42>p {
        font-size: 3.5vw !important;
    }

    .mask-front-content-30>p,
    .mask-front-content-31>p,
    .mask-front-content-32>p {
        font-size: 3.5vw !important;
    }

    p {
        color: rgb(255, 255, 255);
        font-size: 1vw;
    }

    .mask-front-content {
        flex-grow: 1;
        display: flex;
        justify-content: center;
        align-items: center;
        text-align: center;
    }

    .mask-front-content>p {
        /* font-size: 6vw !important; */
    }

    .mask>div {
        display: center;
    }

    /* content-0 */

    /* #content-0{
    height: 75vw;
} */

    #content-0 .mask {
        height: inherit;
        width: inherit;
        /* display: flex; */
        position: absolute;
        float: left;
        z-index: 5;
    }

    .mask-0 {
        height: inherit;
        width: 45vw;
        position: relative;
    }

    .m00 {
        background-color: rgb(25, 46, 67, 0.7);
        /* flex-grow: 1; */
        left: 0;
        float: left;
    }

    .m01 {
        background-color: rgb(255, 55, 68);
        /* flex-grow: 1; */
        float: right;
        right: 0;
        /* animation: content-hover-2item 0.2s ease 0s 1 normal forwards; */
    }

    /* content-1 */

    #content-1 {
        height: 36vw;
    }

    #content-1 .mask {
        display: flex;
        flex-direction: column;
        flex-wrap: wrap;
        grid-template-columns: 1fr 1fr;
        width: 90vw;
        height: 36vw;
        position: absolute;
        float: left;
        z-index: 5;
    }

    .content-1s {
        width: 90vw;
        height: 15vw;
    }

    .mask-1 {
        width: 45vw;
        height: 18vw;
        /* == #content-1 height/2 */
        position: absolute;
    }

    .m10 {
        background-color: rgb(25, 46, 67);
        left: 0;
        float: left;
    }

    .m11 {
        background-color: rgb(255, 55, 68);
        float: right;
        right: 0;
    }

    .m12 {
        background-color: rgb(255, 55, 68);
        left: 0;
        float: left;
        bottom: 0;
    }

    .m13 {
        background-color: rgb(25, 46, 67);
        float: right;
        right: 0;
        bottom: 0;
    }

    /* content-2 */

    #content-2 {
        height: 16vw;
    }

    #content-2 .mask {
        height: inherit;
        width: inherit;
        /* display: flex; */
        position: absolute;
        float: left;
        z-index: 5;
    }

    .mask-2 {
        height: inherit;
        width: 45vw;
        position: relative;
    }

    .m20 {
        background-color: rgb(255, 55, 68);
        /* flex-grow: 1; */
        left: 0;
        float: left;
    }

    .m21 {
        background-color: rgb(25, 46, 67);
        /* flex-grow: 1; */
        float: right;
        right: 0;
        /* animation: content-hover-2item 0.2s ease 0s 1 normal forwards; */
    }

    /* content-3 */

    #content-3 {
        height: 60vw;
    }

    #content-3 .mask {
        display: flex;
        flex-direction: column;
        grid-template-columns: 1fr 1fr;
        width: 90vw;
        height: 75vw;
        position: absolute;
        float: left;
        z-index: 5;
    }

    .mask-3 {
        width: 90vw;
        height: 30vw;
        /* == #content-1 height/2 */
        position: absolute;
    }

    .m30 {
        background-color: rgb(25, 46, 67);
        left: 0;
        float: left;
    }

    .m31 {
        background-color: rgb(255, 55, 68);
        top: 0;
        float: right;
        right: 0;
    }

    .m32 {
        background-color: rgb(25, 46, 67);
        left: 0;
        top: 30vw;
        float: left;
    }

    /* content-4 */
    #content-4 {
        height: 60vw;
    }

    #content-4 .mask {
        display: flex;
        flex-direction: column;
        grid-template-columns: 1fr 1fr;
        width: 90vw;
        height: 75vw;
        position: absolute;
        float: left;
        z-index: 5;
    }

    .mask-4 {
        width: 90vw;
        height: 30vw;
        /* == #content-1 height/2 */
        position: absolute;
    }

    .m40 {
        background-color: rgb(25, 46, 67);
        left: 0;
        float: left;
    }

    .m41 {
        background-color: rgb(255, 55, 68);
        top: 0;
        float: right;
        right: 0;
    }

    .m42 {
        background-color: rgb(25, 46, 67);
        left: 0;
        top: 30vw;
        float: left;
    }

    /* title */

    .title-box-new-des {
        margin: 5vw 5vw 2vw 5vw;
        position: relative;
    }

    .title-big {
        margin: 5vw 25vw;
        width: 50vw;
        height: 10vw;
    }

    .title-big h1 {
        font-size: 6vw !important;
        line-height: 10vw;
    }

    .title-big>.title-box-title {
        border-left-style: none !important;
        border-bottom-style: solid;
        border-color: rgb(255, 55, 68);
        border-bottom-width: 0.2vw;
    }

    .title-0 {
        width: 24vw;
        height: 5vw;
    }

    .title-1 {
        width: 35vw;
        height: 5vw;
    }

    .title-2 {
        width: 16vw;
        height: 5vw;
    }

    .title-3 {
        width: 35vw;
        height: 5vw;
    }

    .title-4 {
        width: 34vw;
        height: 6.8vw;
    }

    .reference-title {
        font-size: 5vw !important;
    }

    .reference-content {
        margin: 5vw;
    }

    .reference-content>p {
        color: rgb(120, 120, 120) !important;
    }

    .title-box-mask {
        position: absolute;
        /* width: 40px; */
        height: inherit;
        background-color: rgb(255, 55, 68);
    }

    .title-box-mask-left {
        left: 0;
    }

    .title-box-mask-right {
        right: 0;
    }

    .title-box-title {
        width: inherit;
        height: inherit;
        border-left-style: solid;
        border-color: rgb(255, 55, 68);
        border-left-width: 0.2vw;
        opacity: 0;
        display: flex;
        justify-content: center;
        align-items: center !important;
    }

    .title-box-title>h1 {
        vertical-align: middle;
        text-align: center;
        /* margin: 0; */
        font-size: 3vw;
        color: rgb(25, 46, 67);
        margin: 0 !important;

    }

    /* rich-content */

    .rich-content-box {
        display: flex;
        flex-direction: row;
        width: inherit;
        height: inherit;
        flex-wrap: wrap;
    }

    .rich-content {
        flex-grow: 1;
        display: flex;
        align-items: center;
    }

    .rich-content-00,
    .rich-content-01 {
        flex-grow: 1;
    }

    .rich-content-00>p,
    .rich-content-01>p {

        font-size: 1.5vw !important;
        color: rgb(25, 46, 67) !important;
        text-align: justify !important;
    }

    .rich-content>p {
        font-size: 1.5vw !important;
        color: rgb(25, 46, 67) !important;
        text-align: justify !important;
    }

    .rich-content-10,
    .rich-content-11,
    .rich-content-12,
    .rich-content-13 {
        width: 45%;
        flex-grow: 1;
        height: 50%;
        padding: 0% 2.5%;
    }

    .rich-content-00,
    .rich-content-01 {
        width: 45%;
        padding: 0% 2.5%;
        height: 100%;
    }

    .rich-content-20,
    .rich-content-21 {
        width: 45%;
        padding: 0% 2.5%;
        height: 100%;
    }

    .rich-content-30,
    .rich-content-31,
    .rich-content-32 {
        width: 100%;
        height: 50%;
        ;
    }

    .rich-content-40,
    .rich-content-41,
    .rich-content-42 {
        width: 100%;
        height: 50%;
        ;
    }

    .introduction {
        margin: 4vw 25vw 3vw 25vw;
    }

    .introduction>p {
        font-size: 1.5vw !important;
        color: rgb(120, 120, 120) !important;
    }

    .img-bg-0,
    .img-bg-1 {
        width: 10vw;
        float: left;
    }

    .img-pd-0,
    .img-pd-1,
    .img-pd-2,
    .img-pd-3 {
        width: 8vw;
        float: left;
    }

    .img-approach-0,
    .img-approach-1 {
        width: 10vw;
        float: left;
    }

    .img-fp-0,
    .img-fp-1,
    .img-fp-2 {
        width: 10vw;
        float: left;
    }

    /* content-0 scale */
    .need-scale-0 {}

    .need-scale-rich-0 {
        /* height: 30vw; */
        /* transform: scaleY(0.3); */
        opacity: 0;
    }

    .rich-content-box-shadow {
        position: absolute;
        width: 90vw;
        display: flex;
        flex-direction: row;
        height: inherit;
        flex-wrap: wrap;
    }

    /* .title-margin{
    margin: 5vw 5vw 2vw 5vw;
}
.left-block{
    width: 0.2vw;
}
.title-mask{
    position: absolute;
    height: 1%;
    width: 16vw;
    background-color: lightcoral;
} */


    /* new css */

    /* all in one end */
    .b_have_border {
        border-left-style: solid;
        border-left-width: 2px;
        border-left-color: rgb(255, 55, 68);
        padding-left: 0.4em;
    }
</style>

<head>
    <!-- standard head -->
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <script type="text/javascript"
        src="https://2019.igem.org/wiki/index.php?title=Team:SYSU-Medicine/js/jquery&action=raw&ctype=text/javascript"></script>
    <link type="text/css" rel="stylesheet"
        href="https://2019.igem.org/wiki/index.php?title=Team:SYSU-Medicine/css/default&action=raw&ctype=text/css" />
    <script type="text/javascript"
        src="https://2019.igem.org/wiki/index.php?title=Team:SYSU-Medicine/js/home&action=raw&ctype=text/javascript"></script>
    <link rel="stylesheet"
        href="https://2019.igem.org/wiki/index.php?title=Team:SYSU-Medicine/css/bootstrap&action=raw&ctype=text/css">
    <script type="text/javascript"
        src="https://2019.igem.org/wiki/index.php?title=Team:SYSU-Medicine/js/bootstrap&action=raw&ctype=text/javascript"></script>
    <link type="text/css" rel="stylesheet"
        href="https://2019.igem.org/wiki/index.php?title=Team:SYSU-Medicine/css/style&action=raw&ctype=text/css" />
    <!-- standard head end -->
    <!-- <script type="text/javascript"
        src="https://2019.igem.org/wiki/index.php?title=Team:SYSU-Medicine/js/description&action=raw&ctype=text/javascript"></script>
    <link type="text/css" rel="stylesheet"
        href="https://2019.igem.org/wiki/index.php?title=Team:SYSU-Medicine/css/description&action=raw&ctype=text/css" /> -->


    <!-- <link type="text/css" rel="stylesheet" href="./Description.css"> -->


    <!-- <script src="./Description.js"></script> -->

    <title>Description</title>

</head>

<body>
    <!-- <div class="debug" style= "position:fixed;top:6rem">
        <a class="a">a</a>
    </div> -->
    <div class="container">
        <div class="row">
            <div class="col-sm-12 column">
                <nav class="navigation" id="nav-top">
                    <ul class="navigation-list nav-justified">
                        <div class="navigation-blue navigation-div">
                            <li class="navigation-item activate ">
                                <a class="navigation-item-link "
                                    href="https://2019.igem.org/Team:SYSU-Medicine">Home</a>
                                <ul class="navigation-dropdown-panel"></ul>
                            </li>
                            <li class="navigation-item dropdown">
                                <a class="navigation-item-link ">Project</a>
                                <ul class="navigation-dropdown-panel ">
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/Description">Description</a>
                                    </li>
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/Design">Design</a>
                                    </li>
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/Results">Results</a>
                                    </li>
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/Experiments">Experiments</a>
                                    </li>
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/Inspiration">Inspiration</a>
                                    </li>
                                </ul>
                            </li>
                            <li class="navigation-item dropdown">
                                <a class="navigation-item-link">Model</a>
                                <ul class="navigation-dropdown-panel">
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/Model">Overview</a>
                                    </li>
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/M1_Cultivation">M1 Cultivation
                                        </a>
                                    </li>
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/Injection_System">Injection
                                            System
                                        </a>
                                    </li>
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/TES">T. E. S.</a>
                                    </li>
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/Future">Future</a>
                                    </li>
                                </ul>
                            </li>
                            <li class="navigation-item dropdown ">
                                <a class="navigation-item-link">Human Practices</a>
                                <ul class="navigation-dropdown-panel ">
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/Human_Practices">Overview
                                        </a>
                                    </li>
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/Integrated_Practices">Integrated
                                            Practices
                                        </a>
                                    </li>
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/Public_Engagement">Education &
                                            Engagement
                                        </a>
                                    </li>
                                </ul>
                            </li>

                        </div>
                        <div class="navigation-red navigation-div">
                            <li class="navigation-item dropdown ">
                                <a class="navigation-item-link ">Parts</a>
                                <ul class="navigation-dropdown-panel ">
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/Parts">Parts Overview</a>
                                    </li>
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/Parts#Basic_Part">Basic
                                            Parts</a>
                                    </li>
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/Parts#Composite_Part">Composite
                                            Parts
                                        </a>
                                    </li>
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/Parts#Part_Collection">Part
                                            Collection
                                        </a>
                                    </li>
                                </ul>
                            </li>

                            <li class="navigation-item ">
                                <a class="navigation-item-link"
                                    href="https://2019.igem.org/Team:SYSU-Medicine/Safety">Safety</a>
                                <ul class="navigation-dropdown-panel"></ul>
                            </li>
                            <li class="navigation-item ">
                                <a class="navigation-item-link"
                                    href="https://2019.igem.org/Team:SYSU-Medicine/Medal">Awards</a>
                                <ul class="navigation-dropdown-panel">
                                    <li class="navigation-subitem">
                                        <a href="https://igem.org/2019_Judging_Form?team=SYSU-Medicine">Judging</a>
                                    </li>
                                </ul>
                            </li>
                            <li class="navigation-item dropdown ">
                                <a class="navigation-item-link ">Team</a>
                                <ul class="navigation-dropdown-panel ">
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/Team">Team Members</a>
                                    </li>
                                    <li class="navigation-subitem">
                                        <a
                                            href="https://2019.igem.org/Team:SYSU-Medicine/Collaborations">Collaborations</a>
                                    </li>
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/Attributions">Attributions</a>
                                    </li>
                                </ul>
                            </li>
                        </div>

                    </ul>
                </nav>
            </div>
        </div>
    </div>
    <!-- <div class="piano-subpage piano-subpage-demo">
    <div id="content-0-key" class="piano-subpage-key piano-subpage-key-0"><div class="key-kernel key-kernel-0"></div></div>
    <div id="content-1-key" class="piano-subpage-key piano-subpage-key-1"><div class="key-kernel key-kernel-1"></div></div>
    <div id="content-2-key" class="piano-subpage-key piano-subpage-key-2"><div class="key-kernel key-kernel-2"></div></div>
    <div id="content-3-key" class="piano-subpage-key piano-subpage-key-3"><div class="key-kernel key-kernel-3"></div></div>
    <div id="content-4-key" class="piano-subpage-key piano-subpage-key-4"><div class="key-kernel key-kernel-4"></div></div>
    <div id="content-5-key" class="piano-subpage-key piano-subpage-key-5"><div class="key-kernel key-kernel-5"></div></div>
    </div> -->
    <!-- <div class="title-margin">
        <div class="row clearfix">
            <div class="col-xs-10">
                <div class="title-box">
                    <h1 class="title">
                        <span class="title-has-mask playing">Human Practices</span>
                        <span class="title-mask playing"></span>
                    </h1>
                </div>
            </div>
        </div>
    </div> -->
    <div class="title-box-new-des title-big">
        <div class="title-box-mask"></div>
        <div class="title-box-title">
            <h1>DESCRIPTION</h1>
        </div>
    </div>
    <div class="title-box-new-des title-0">
        <div class="title-box-mask"></div>
        <div class="title-box-title">
            <h1>Background</h1>
        </div>
    </div>
    <div class="introduction">
        <p>
            “Cancer is the second leading cause of death globally, and is responsible for an estimated 9.6 million
            deaths in 2018. Globally, about 1 in 6 deaths is due to cancer.”</p>
        <p style="text-align: right;"> ——WHO
        </p>

    </div>
    <div class="sub-content need-scale need-scale-0" id="content-0">
        <div class="switch"></div>
        <div class="mask-front-content-box">
            <div class="mask-front-content mask-front-content-00">
                <p>Cancer and<br> Therapies
                </p>
            </div>
            <div class="mask-front-content mask-front-content-01">
                <p>
                    M1

                </p>
            </div>
        </div>

        <div class="mask mask-0-box">
            <div class="mask-0 m00">

            </div>
            <div class="mask-0 m01">

            </div>
        </div>
        <div class="content-0-all">
            <div class=" rich-content-box-shadow">
                <div class=" rich-content-00">
                    <img src="https://2019.igem.org/wiki/images/thumb/d/d7/T--SYSU-Medicine--background_1.png/1600px-T--SYSU-Medicine--background_1.png"
                        class="img-bg-1">
                    <p>
                        Needless to say, there are tons of data on the importance and dangers of
                        cancer,
                        but it was only when
                        we came to the hospital to practice that we really realized how prevailing and frightening this
                        disease is. We have witnessed with our own eyes the suffering of our patients, the incessant
                        coughing of patients with lung cancer, the excruciating appearance of patients with stomach
                        cancer,
                        and the huge abdomen filled with ascites of patients with liver cancer.
                    </p>
                    <p>
                        All this moved us deeply, and led us to think deeply ——how can we
                        actually
                        relieve their pain? What efforts can we make as a group of medical students?</b>
                    </p>

                </div>
                <div class=" rich-content-01 ">
                    <img src="https://2019.igem.org/wiki/images/thumb/4/4a/T--SYSU-Medicine--background_2.png/1600px-T--SYSU-Medicine--background_2.png"
                        class="img-bg-0">
                    <p>M1 is a strain of Getah-like alphavirus that was isolated from culicine
                        mosquitoes collected on
                        Hainan Island of China which possesses selective and potent antitumor activity through
                        intravenous administration [2].</p>
                    <p>

                        Compared with other oncolytic virus, the most significant advantage of M1 is
                        that it is highly safe
                        and can be injected intravenously. Getah virus is transmitted mainly among horses and pigs, and
                        it
                        has not been linked to human illness [3].
                    </p>
                    <p>
                        At the same time, studies have shown that M1 has a broad anti-cancer

                    </p>
                </div>
            </div>

            <div class="rich-content-box ">
                <div class=" rich-content-00 need-scale need-scale-rich-0">
                    <img src="https://2019.igem.org/wiki/images/thumb/d/d7/T--SYSU-Medicine--background_1.png/1600px-T--SYSU-Medicine--background_1.png"
                        class="img-bg-1">
                    <p>
                        <b class="b_have_border">Cancer and Therapies</b><br>Needless to say, there are tons of data on
                        the importance and
                        dangers of cancer, but it was only
                        when we came to the hospital to practice that we really realized how prevailing and frightening
                        this
                        disease is. We have witnessed the suffering of our patients, the incessant coughing of patients
                        with
                        lung cancer, the excruciating appearance of patients with stomach cancer, and the huge abdomen
                        filled with ascites of patients with liver cancer.</p>
                    <p><b>All this moved us deeply, and made us ponder -- how can we actually relieve their pain? What
                            efforts
                            can we make as a group of medical students?
                        </b></p>
                    <p>
                        Nowadays, targeted and immune-based therapies have already transformed the standard-of‑care for
                        several malignancies. Oncolytic virus, as an attractive therapeutic combination of the advantage
                        of
                        tumor-specific cell lysis together with immune stimulation, are emerging as important agents in
                        cancer treatment.</p>








                </div>
                <div class=" rich-content-01 need-scale need-scale-rich-0">
                    <img src="https://2019.igem.org/wiki/images/thumb/4/4a/T--SYSU-Medicine--background_2.png/1600px-T--SYSU-Medicine--background_2.png"
                        class="img-bg-0">
                    <p><b class="b_have_border">M1</b><br>M1 is a strain of Getah-like alphavirus that was isolated from
                        culicine mosquitoes
                        collected on Hainan Island of China which possesses selective and potent antitumor activity
                        through intravenous administration [1].</p>
                    <p>Compared with other oncolytic virus, the most significant advantage of M1 is that it is highly
                        safe
                        and can be injected intravenously. Getah virus is transmitted mainly among horses and pigs, and
                        it
                        has not been linked to human illness [2]. <a
                            href="https://2019.igem.org/Team:SYSU-Medicine/Safety">[See more in our Safety part]</a></p>
                    <p>At the same time, studies have shown that M1 has a broad anti-cancer spectrum. It can selectively
                        infect and kill 13 kinds of refractory high-incidence malignant tumor cells through triple
                        mechanism
                        of direct oncolytic, peripheral cell killing and immune activation, but has no killing effect on
                        normal cells[3].</p>
                    <p>To sum up, oncolytic virus M1 has the advantages of broad anti-tumor spectrum, safety,
                        effectiveness, precision treatment, etc. It has a good potential for cancer treatment and could
                        serve as a good foundation and platform for further synthetic biology research.</p>








                </div>
            </div>
        </div>




    </div>


    <div class="title-box-new-des title-0">
        <div class="title-box-mask"></div>
        <div class="title-box-title">
            <h1>Mechanism</h1>
        </div>
    </div>
    <div class="container-fluid">
        <style type="text/css">
            .panel-title {
                font-size: 2em !important;
                color: rgb(25, 46, 67);
            }

            .panel-body {
                border-top: 1px solid #ddd;
                display: flex;
                flex-direction: column;
                align-items: center;
                justify-content: center;

            }

            .panel-body img {
                width: 90%;
            }

            .panel-body p {
                color: rgb(25, 46, 67);
                font-size: 1.5em;

                text-indent: 1em;
                text-align: justify !important;
            }

            /*去掉ul默认的点*/

            .timeline ul {
                list-style: none;
            }

            /*时间轴的线条*/

            .timeline ul li {
                list-style-type: none;
                position: relative;
                width: 24px;
                margin: 0 100px;
                padding-top: 50px;
                background: rgba(36, 59, 82, 0.38);
                /*background: linear-gradient(180deg, rgba(255, 55, 68, 0), rgba(255, 55, 68, 0.5));*/
                /*动画*/
                transition: all 0.5s ease-in-out;

            }

            /*时间轴最后的箭头*/

            .timeline ul li:last-of-type:after {
                /*-webkit-clip-path: polygon(50% 0%, 100% 25%, 100% 75%, 50% 100%, 0% 75%, 0% 25%);
        clip-path: polygon(50% 0%, 100% 25%, 100% 75%, 50% 100%, 0% 75%, 0% 25%);*/
                content: '';
                /*隐藏了*/
                /*visibility: hidden;*/
                position: absolute;
                /*bottom: -4%;*/
                width: 0px;
                height: 0px;
                left: -24px;
                border-width: 36px;
                border-style: solid;
                border-color: rgba(36, 59, 82, 0.38) white white white;
                margin: 0;
                padding: 0;
                box-sizing: border-box;
                z-index: 2;
                color: white;

            }

            /* 时间轴旁边的卡片 */

            .timeline ul li>div {
                position: relative;
                bottom: 0;
                width: 700px;
                width: calc(70vw - 15px);
                width: -webkit-calc(70vw - 15px);
                flex-direction: column;
                padding: 20px;
                background: #fff;
                box-shadow: 4px 6px 12px 1px rgba(25, 46, 67, 0.2);
                border-radius: 5px;
                display: flex;
                align-items: initial;
                /*visibility: hidden;*/
            }

            /*圆圈*/

            .timeline ul li time {
                /*绝对定位*/
                position: absolute;
                /*background: #f5af19;*/
                font-size: 100%;
                width: 100px;
                height: 100px;
                border-radius: 50%;
                /*top: -50px;*/
                left: -38px;
                /*border-style:solid;
        border-color: rgba(252, 56, 56, 0.2);*/
                background: rgb(66, 95, 123);
                color: white;
                display: flex;
                justify-content: center;
                align-items: center;
                letter-spacing: 2px;

                /*-webkit-clip-path: polygon(50% 0%, 100% 25%, 100% 75%, 50% 100%, 0% 75%, 0% 25%);
        clip-path: polygon(50% 0%, 100% 25%, 100% 75%, 50% 100%, 0% 75%, 0% 25%);*/
                z-index: 10;
                box-shadow: 0px 4px 5px 2px #192e4387;
                /*动画 消失和出现*/
                /*transition: all 0.5s ease-in-out;*/
                /*visibility: hidden;*/


            }

            /*卡片内部的小框
    
    .timeline ul li div>div {
        display: flex;
        width: 95%;
        /*内部的弹性盒元素的排列方向
        flex-direction: column;
        justify-content: center;
        align-items: center;
    }*/
            /*卡片内部的框内部的段落*/

            .timeline ul li div div p {
                text-align: left;
            }

            .timeline ul li a {
                color: black;
                text-align: left;
            }

            /*卡片内部的小框的外间距*/

            .timeline ul li div>div {
                margin-top: 10px;
                margin-bottom: 10px;
                margin-left: 10px;
                margin-right: 10px;
            }

            /* 奇数编号的卡片 相对于时间轴的位置（relative） */

            .timeline ul li>div {
                left: 100px;
            }

            /*变色动画部分开始*/
            /*变色动画部分开始*/

            .timeline ul li div {
                /*visibility: hidden;
        opacity: 0;*/
                /*控制所有卡片及其内部元素的动画速度*/
                /*color: gray;*/
                /*transition: all 0.5s ease-in-out;*/
            }

            .timeline ul li:nth-of-type(odd) div {
                /*transform: translate3d(100px, -10px, 0) rotate(10deg);
        -webkit-transform: translate3d(100px, -10px, 0) rotate(10deg);*/
            }

            .timeline ul li.in-view {
                /*background: rgba(255, 55, 68, 0.8);*/
                /*background: linear-gradient(180deg, rgba(255, 55, 68, 0.5), rgba(255, 55, 68, 1));*/
            }

            .timeline ul li.in-view div {
                /* 消除静态属性，或者修改属性值，就会发生动画transition */
                /*visibility: visible;*/
                /*transform: none;*/
                /*-webkit-transform: none;*/
                /*color: rgba(25, 46, 67, 1);*/
            }

            .timeline ul li.in-view time {
                /*visibility: visible;*/
            }

            /*.timeline ul li.in-view div time {
        color: white;
    }*/
            /*变色动画部分结束*/
            /*移动适配*/

            @media screen and (max-width: 900px) {
                .timeline ul li div {
                    width: 350px;
                    width: calc(80vw - 200px);
                    width: -webkit-calc(80vw - 200px);
                    flex-direction: column;
                }

                .timeline ul li div div {
                    width: 95%;
                    margin: 10px;
                }
            }

            @media screen and (max-width: 600px) {
                .timeline ul li {
                    margin-left: 15px;
                    left: 40px;
                }

                .timeline ul li div {
                    left: 80px;
                    width: 300px;
                    width: calc(100vw - 200px);
                    width: -webkit-calc(100vw - 200px);
                }
            }
        </style>
        <div class="row">
            <div class="col-xs-12">
                <section class="timeline">
                    <ul>

                        <li>
                            <time> </time>
                            <div>
                                <div class="panel-heading">
                                    <h3 class="panel-title">
                                        【Therapies】
                                    </h3>
                                </div>
                                <div class="panel-collapse collapse in">
                                    <div class="panel-body">
                                        <p>During the past two decades, the paradigm for cancer treatment has evolved
                                            from relatively
                                            non-specific cytotoxic agents to selective, mechanism-based therapeutics.
                                        </p>
                                        <p>Cancer chemotherapies were initially identified through screens for compounds
                                            that killed
                                            rapidly
                                            dividing cells. Take actinomycin as an example, antibiotics of actinomycin
                                            series are
                                            classic
                                            drugs
                                            for tumor chemotherapy. This application is based on the ability of
                                            actinomycins to form
                                            specific
                                            stable complexes with DNA, leading to inhibition of RNA polymerase reaction
                                            and resulting in
                                            suppression of protein synthesis and cell division [4]. These drugs remain a
                                            backbone of
                                            current
                                            treatment, but are limited by a narrow therapeutic index, significant
                                            toxicities, and
                                            frequently
                                            acquired resistance.
                                        </p>
                                        <p> More recently, an improved understanding of cancer pathogenesis has given
                                            rise to new
                                            treatment
                                            options, including targeted agents and cancer immunotherapy. Targeted
                                            approaches aim to
                                            inhibit
                                            molecular pathways that are critical to tumor growth and maintenance,
                                            whereas immunotherapy
                                            endeavors to stimulate a host response that effectuates long-lived tumor
                                            destruction [5].
                                        </p>
                                        <p>The integration of these potentially complementary research fields provides
                                            new opportunities
                                            to
                                            improve cancer treatments. Additional insights into the effects of targeted
                                            therapies, along
                                            with
                                            conventional chemotherapy and radiation therapy, on the induction of
                                            antitumor immunity will
                                            help to
                                            advance the design of combination strategies that increase the rate of
                                            complete and durable
                                            clinical
                                            response in patients [6].</p>
                                        <img src="https://2019.igem.org/wiki/images/4/4d/T--SYSU-Medicine--des_2.png">
                                        <p style="font-size: 1em;" class="fig-text">Figure 1.Fukuhara, H., Y. Ino and T.
                                            Todo, Oncolytic virus therapy: A new era of cancer treatment at dawn. Cancer
                                            Sci, 2016. 107(10): p. 1373-1379. </p>

                                    </div>
                                </div>

                            </div>
                        </li>
                        <li>
                            <time> </time>
                            <div>
                                <div class="panel-heading">
                                    <h3 class="panel-title">
                                        【Oncolytic Virus】
                                    </h3>
                                </div>
                                <div class="panel-collapse collapse in">
                                    <div class="panel-body">
                                        <p>Oncolytic virus (OV) immunotherapy is a therapeutic approach to cancer
                                            treatment that
                                            utilizes
                                            native or genetically modified viruses that selectively replicate within
                                            tumor cells. OVs
                                            mediate antitumor activity through two distinct mechanisms of action:
                                            selective replication
                                            within neoplastic cells, resulting in a direct lytic effect on tumor cells
                                            and induction of
                                            systemic antitumor immunity [7].</p>
                                        <p>The tumor selectivity of OVs is largely conferred by tumor-specific
                                            aberrations in signaling
                                            pathways that normally sense and block viral replication [8]. It is now well
                                            established
                                            that
                                            cancer-specific aberrations in RAS, TP53, RB1, PTEN, genes encoding proteins
                                            involved in the
                                            WNT
                                            signaling pathway and other cancer-related genes can predispose cancer cells
                                            to virus
                                            infection
                                            [9]. This is due to crosstalk between oncogenic signaling and antiviral
                                            pathways, which
                                            creates
                                            a permissive environment for viral replication.</p>
                                        <p>The immune response to oncolytic viruses appears to be a more important
                                            component of the
                                            antitumor effect. In nature, viruses have evolved multiple strategies to
                                            overcome immune
                                            attack,
                                            enabling OVs to promote an immune response against the tumor cells by
                                            allowing tumor antigen
                                            presentation in the context of an active viral infection.</p>
                                        <img src="https://2019.igem.org/wiki/images/a/aa/T--SYSU-Medicine--des_3.png">
                                        <p style="font-size: 1em;" class="fig-text">Figure 2.Fukuhara, H., Y. Ino and T.
                                            Todo, Oncolytic virus therapy: A new era of cancer treatment at dawn. Cancer
                                            Sci, 2016. 107(10): p. 1373-1379. </p>
                                        <img src="https://2019.igem.org/wiki/images/5/5d/T--SYSU-Medicine--des_4.png">
                                        <p style="font-size: 1em;" class="fig-text">Figure 3.Fukuhara, H., Y. Ino and T.
                                            Todo, Oncolytic virus therapy: A new era of cancer treatment at dawn. Cancer
                                            Sci, 2016. 107(10): p. 1373-1379. </p>
                                        <p>As we gain a more complete understanding of the molecular interplay between
                                            viruses and our
                                            immune systems, it becomes increasingly possible to design therapeutic
                                            strategies that turn
                                            viruses from stealth pathogens to finely tuned ‘viroceuticals’ that initiate
                                            both
                                            viral-mediated
                                            and immune-mediated attacks against cancers [10].</p>
                                        <p>The effectiveness of OVs has been demonstrated in many preclinical studies
                                            and recently in
                                            humans, with US Food and Drug Administration approval of the oncolytic
                                            herpesvirus
                                            Talimogene
                                            laherparepvec (T-Vec) in advanced melanoma, a breakthrough for the field
                                            [11]. Moreover,
                                            some of
                                            the cancer-targeted multimechanistic oncolytic viruses have been proven to
                                            be well-tolerated
                                            in
                                            clinical trials, with patients exhibiting only mild flu-like symptoms,
                                            offering great
                                            potential
                                            for increasing efficacy while eliminating the side effects [12]. Thus, the
                                            OV approach to
                                            cancer
                                            therapy is becoming more interesting for scientists, clinicians, and the
                                            public.
                                        </p>
                                    </div>
                                </div>

                            </div>
                        </li>
                        <li>
                            <time> </time>
                            <div>
                                <div class="panel-heading">
                                    <h3 class="panel-title">
                                        【M1】
                                    </h3>
                                </div>
                                <div class="panel-collapse collapse in">
                                    <div class="panel-body">
                                        <P>As mentioned above, M1 virus was first isolated from culicine mosquitoes in
                                            Baoting Li and
                                            Miao
                                            autonomous county, Hainan island in 1964. Phylogenetic analysis showed that
                                            M-1 grouped with
                                            GETV first and then grouped together with SAGV. The genome of M1 is
                                            single-plus RNA, with a
                                            total length of 11,696 nt, encoding 4 non-structural proteins (NS1, NS2, NS3
                                            and RdRP) and 5
                                            structural proteins (E1, E2, E3, C and 6K) [13].</P>
                                        <P> Compared with the oncolytic virus (including modified poxvirus, herpes
                                            virus, measles virus,
                                            Newcastle disease virus, etc.) currently in clinical trials and the approved
                                            H101 and T-Vec
                                            viruses, the most significant advantage of M1 is that it is highly safe and
                                            can be injected
                                            intravenously. Getah virus, which is highly similar to M1 virus, mainly
                                            infects horses and
                                            pigs,
                                            causing mild symptoms such as fever, rash, edema of hind limbs and enlarged
                                            lymph nodes, and
                                            generally recovered within 1 week, presenting a benign course [14]. Although
                                            Getah virus is
                                            widely distributed in southeast Asia, Australia, Japan, Mongolia, Russia and
                                            China, no human
                                            diseases caused by Getah virus have been reported so far. Domestic and
                                            foreign
                                            epidemiological
                                            studies have shown that Getah virus antibody can be detected in normal
                                            people, which
                                            explains
                                            the advantages of a virus with lower risk of disease from another
                                            perspective [15].</P>
                                        <img src="https://2019.igem.org/wiki/images/5/56/T--SYSU-Medicine--des_5.png">
                                        <p style="font-size: 1em;" class="fig-text">Figure 4.Taguchi, S., et al.,
                                            Current status of clinical trials assessing oncolytic virus therapy for
                                            urological cancers. International Journal of Urology, 2017. 24(5): p.
                                            342-351. </p>
                                        <P>At the same time, studies have shown that oncolytic virus M1 has a broad
                                            anti-cancer
                                            spectrum.
                                            It can selectively infect and kill 13 kinds of refractory high-incidence
                                            malignant tumor
                                            cells
                                            through triple mechanism of direct oncolytic, peripheral cell killing and
                                            immune activation,
                                            but
                                            has no killing effect on normal cells. Studies have shown [16-18] that key
                                            molecular
                                            mechanisms
                                            of oncolytic virus M1 targeting tumor cells include zinc finger antiviral
                                            protein ZAP, RHO
                                            family protein TC10, and UPR signaling molecule IRE1α. These three proteins
                                            play an
                                            antiviral
                                            role in the intracellular life history of M1: ZAP binds and degrades viral
                                            RNA; TC10
                                            inhibits
                                            virus transport; IRE1α removes viral proteins by activating autophagy. Their
                                            low expression
                                            in
                                            tumors allows M1 virus to selectively replicate in large numbers of tumor
                                            cells and play a
                                            role
                                            in its oncolytic effect.</P>
                                        <img src="https://2019.igem.org/wiki/images/c/c7/T--SYSU-Medicine--des_6.png">
                                        <p style="font-size: 1em;" class="fig-text">Figure 5. Y. Lin, H. Zhang, J.
                                            Lianget al. Identification and characterization of alphavirus M1 as a
                                            selective oncolytic virus targeting ZAP-defective human cancers. Proceedings
                                            of the National Academy of Sciences of the United States of
                                            America，2014;111（42）：E4504-E4512. </p>
                                        <P>Overall animal experiments showed that M1 injected by caudal vein and
                                            intratumoral injection
                                            could significantly accumulate in tumor tissues and inhibit tumor growth,
                                            while normal
                                            organs
                                            were not affected. In addition to cell and animal experiments, the oncolytic
                                            effect of
                                            oncolytic
                                            virus M1 ex vivo was further confirmed [16]</P>
                                        <P>Despite all those advantages of M1, however, results from normal and tumor
                                            cell models,
                                            immunodeficient and immunohealthy tumor-bearing mice models, and ex vivo
                                            clinical tumor
                                            culture
                                            models have revealed its drawbacks. The sensitivity rate of the cell model
                                            was 48% (32/67
                                            tumor
                                            cells) and that of the ex vivo model was 36% (17/47 tumor samples) [3].
                                            Obviously, the
                                            existing
                                            oncolytic virus M1 still has the necessary and development space to enhance
                                            the anti-tumor
                                            spectrum and anti-cancer activity.</P>
                                        <img src="https://2019.igem.org/wiki/images/9/92/T--SYSU-Medicine--des_1.jpg">

                                        <p style="font-size: 1em;" class="fig-text">Figure 6. Sensitivity of tumor cells
                                            and in vitro
                                            living tissue to oncolytic
                                            virus M1. A) of the 67 tumor cells, 32 were sensitive to M1, with A
                                            sensitivity rate of 48%.
                                            B) among the 47 clinical tumor specimens, 17 were sensitive to M1, with a
                                            sensitivity rate
                                            of 36%. Sensitive cells or cases are shown in red. [3] </p>
                                    </div>
                                </div>

                            </div>
                        </li>
                        <li>
                            <time> </time>
                            <div>
                                <div class="panel-heading">
                                    <h3 class="panel-title">
                                        <a data-toggle="collapse" data-parent="#accordion" href="#step-1">
                                            【Improvement】
                                        </a>
                                    </h3>
                                </div>
                                <div class="panel-collapse collapse in">
                                    <div class="panel-body">
                                        <p>It is generally believed that the limited application of M1 virus is mainly
                                            attributed to
                                            pathways involved by ZAP, RHOQ, IRE1α and MXRA8 in insensitive tumor cells,
                                            lead to the
                                            impairment of invasion and replication of the virus [18]. Research shows
                                            that using
                                            inhibitors
                                            to reduce those protein levels can to some extent improve the curative
                                            effect of oncolytic
                                            viruses in several tumors, which may be a clue to further research.</p>
                                        <p>However, since the underlying genesis and development mechanism of tumor
                                            itself is still far
                                            from being thoroughly studied, it is unrealistic to increase M1 infection
                                            rate by studying
                                            the
                                            pathway of tumor cells one by one. <b>It is more reasonable to find a
                                                solution
                                                so that the
                                                anti-cancer spectrum of M1 can no longer be restricted by the
                                                limitations of
                                                the pathways in
                                                tumor cells.</b> In other words, could we find a pathway more upstream
                                            than ZAP,
                                            TC10 and IRE1α,
                                            that is common to all tumor cells, to be utilized by M1?</p>

                                        <img src="https://2019.igem.org/wiki/images/b/bd/T--SYSU-Medicine--des_8.jpg">

                                        <p style="font-size: 1em;" class="fig-text">Figure 7. Diagram of the growth
                                            signaling circuitry of the mammalian cell, which may serve as potential
                                            anti-tumor targets [20]. </p>
                                        <p>One of the most remarkable features of tumors is their limitless replicative
                                            potential which
                                            was
                                            acquired during tumor progression and was essential for the development of
                                            their malignant
                                            growth state [19]. The ability of unlimited proliferation is reflected in
                                            the hyperactive
                                            transcription process at the cellular level. Therefore, we want to find a
                                            means to interfere
                                            with tumor cells at the transcriptional level and then enhance the infection
                                            rate and
                                            lethality
                                            of M1.</p>
                                        <p>Surprisingly, many chemotherapy drugs work through this mechanism.
                                            Actinomycin D, as a
                                            typical
                                            representative among actinomycins, has been widely used in clinical practice
                                            since 1954 as
                                            an
                                            anticancer drug for treating many tumors. The two main mechanisms of its
                                            anti-tumor ability
                                            are
                                            intercalation to DNA and the stabilization of cleavable complexes of
                                            topoisomerases I and II
                                            with DNA, which interferes with cell transcription, but does not affect
                                            alphavirus
                                            replication
                                            or cytopathic vacuoles formation [20].
                                        </p>
                                        <img src="https://2019.igem.org/wiki/images/0/06/T--SYSU-Medicine--des_9.png">

                                        <p style="font-size: 1em;" class="fig-text">Figure 8. Sites for inhibition of
                                            nucleic acid synthesis by antibiotics and drugs. Waring, M. J. (1981). DNA
                                            Modification and Cancer. Annual Review of Biochemistry, 50(1), 159–192. </p>
                                        <p> As early as 1963, a study suggested that actinomycin D could enhance the
                                            growth of
                                            Chikungunya
                                            virus, which is also an alphavirus, within tumor cells through some cellular
                                            mechanism [21].
                                            Also, the yield of SFV could be increased at least 50% in the cells
                                            pretreated with
                                            actinomycin
                                            D [20]. More studies have also confirmed that actinomycin D promotes the
                                            replication of
                                            alphavirus in tumor cells significantly, for it can help to suppress
                                            cellular functions
                                            which
                                            inhibit production of infectious virus particles. Those possible mechanism
                                            may include
                                            interferon and cyclopentenone prostaglandin A1 (PGA1) [21-23].</p>
                                        <p> These chemotherapies, which act on the transcription process, could
                                            effectively increase the
                                            infection rate of M1 against a variety of tumor cells, however, the
                                            broad-spectrum effect
                                            also
                                            causes serious side effects. All this suggests that there might be a
                                            feasible way to expand
                                            the
                                            anti-cancer profile of M1 while reducing the side effects of chemotherapy
                                            drugs by combining
                                            the
                                            therapies together, fostering their strengths and circumventing the
                                            weaknesses.</p>
                                    </div>
                                </div>

                            </div>
                        </li>
                        <!-- <li>
                            <time> </time>
                            <div>
                                <div class="panel-heading">
                                    <h3 class="panel-title">
                                        <a data-toggle="collapse" data-parent="#accordion" href="#step-1">
                                            []]
                                        </a>
                                    </h3>
                                </div>
                                <div class="panel-collapse collapse in">
                                    <div class="panel-body">
                                        <p></p>
                                    </div>
                                </div>

                            </div>
                        </li> -->

                    </ul>
                </section>
            </div>

        </div>
    </div>


























    <div class="title-box-new-des title-1">
        <div class="title-box-mask"></div>
        <div class="title-box-title">
            <h1>Problem Definition</h1>
        </div>
    </div>
    <div class="sub-content" id="content-1">
        <div class="switch"></div>
        <div class="mask-front-content-box ">
            <div class="mask-front-content mask-front-content-10">
                <p>【Shortages of Current Cancer Therapies】


                </p>
            </div>
            <div class="mask-front-content mask-front-content-11">
                <p>
                    【limitations of NTR/CB1954】

                </p>
            </div>
            <div class="mask-front-content mask-front-content-12">
                <p>
                    【Low Sensitivity of M1】

                </p>
            </div>
            <div class="mask-front-content mask-front-content-13">
                <p>
                    【Lack of Effective Regulation】

                </p>
            </div>
        </div>
        <div class="mask mask-1-box">

            <div class="content-1s">
                <div class="mask-1 m10"></div>
                <div class="mask-1 m11"></div>


            </div>
            <div class="content-1s">
                <div class="mask-1 m12"></div>
                <div class="mask-1 m13"></div>
            </div>
        </div>
        <div class="rich-content-box rich-content-box-1">
            <div class="rich-content rich-content-10">
                <img src="https://2019.igem.org/wiki/images/thumb/2/2a/T--SYSU-Medicine--problem_definition_1.png/1600px-T--SYSU-Medicine--problem_definition_1.png"
                    class="img-pd-0">
                <p><b class="b_have_border">Shortages of Current Cancer Therapies</b><br>
                    Current cancer treatments are either limited in their effectiveness or have large side effects.
                </p>
            </div>
            <div class="rich-content rich-content-11">
                <img src="https://2019.igem.org/wiki/images/thumb/7/7e/T--SYSU-Medicine--problem_definition_2.png/1600px-T--SYSU-Medicine--problem_definition_2.png"
                    class="img-pd-1">
                <p><b class="b_have_border">limitations of NTR/CB1954</b><br>
                    CB1954 could be activated by NTR and causes DNA–DNA interstrand cross-links to form within the
                    cells. These cross-links are poorly repaired, and lead to cell death in both dividing and
                    non-dividing cells [5].
                </p>
            </div>
            <div class="rich-content rich-content-12">
                <img src="https://2019.igem.org/wiki/images/thumb/b/b8/T--SYSU-Medicine--problem_definition_3.png/1600px-T--SYSU-Medicine--problem_definition_3.png"
                    class="img-pd-2">
                <p><b class="b_have_border">Low Sensitivity of M1</b><br>
                    Oncolytic virus M1 may be a viable solution for its high targeting ability and broad anticancer
                    spectrum, however, it does not have a significant oncolytic effect on all subtypes of tumor cells.
                </p>
            </div>
            <div class="rich-content rich-content-13">
                <img src="https://2019.igem.org/wiki/images/thumb/d/d9/T--SYSU-Medicine--approach_2.png/1600px-T--SYSU-Medicine--approach_2.png"
                    class="img-pd-3">
                <p><b class="b_have_border">Lack of Effective Regulation</b><br>
                    Although M1 virus is safe to normal cells and not pathogenic to humans, as an RNA virus with a high
                    mutation rate, further application of M1 virus requires it to be more controllable if its potential
                    as a tool of synthetic biology is to be fully realized.
                </p>
            </div>
        </div>


    </div>
    <div class="title-box-new-des title-2">
        <div class="title-box-mask"></div>
        <div class="title-box-title">
            <h1>Approach</h1>
        </div>
    </div>
    <div class="sub-content" id="content-2">
        <div class="switch"></div>
        <div class="mask-front-content-box">
            <div class="mask-front-content mask-front-content-20">
                <p>
                    Enzyme Prodrug System
                </p>
            </div>
            <div class="mask-front-content mask-front-content-21">
                <p>
                    Riboswitch

                </p>
            </div>
        </div>
        <div class="mask mask-2-box">
            <div class="mask-2 m20"></div>
            <div class="mask-2 m21"></div>
        </div>
        <div class="rich-content-box">
            <div class="rich-content rich-content-20">
                <img src="https://2019.igem.org/wiki/images/thumb/6/60/T--SYSU-Medicine--approach_1.png/1600px-T--SYSU-Medicine--approach_1.png"
                    class="img-approach-0">
                <p><b class="b_have_border">Enzyme Prodrug System</b><br>
                    Our project is to engineer M1 to specifically encode and express enzymes that can convert
                    prodrugs
                    into active therapeutic metabolites, and enhance bystander effects.
                </p>
            </div>
            <div class="rich-content rich-content-21">
                <img src="https://2019.igem.org/wiki/images/thumb/d/d9/T--SYSU-Medicine--approach_2.png/1600px-T--SYSU-Medicine--approach_2.png"
                    class="img-approach-1">
                <p><b class="b_have_border">Riboswitch</b><br>
                    We also utilize riboswitch to enhance the dynamic regulation of M1. It comprises a ribozyme actuator
                    and RNA aptamer sensor and is engineered into the genome and subgenome 5’UTR.
                </p>
            </div>
        </div>



    </div>
    <div class="title-box-new-des title-3">
        <div class="title-box-mask"></div>
        <div class="title-box-title">
            <h1>Future Perspectives</h1>
        </div>
    </div>
    <div class="sub-content" id="content-3">
        <div class="switch"></div>
        <div class="mask-front-content-box">
            <!-- <div class="mask-front-content mask-front-content-30">
                <p>Building better oncolytic virus
                </p>
            </div> -->
            <div class="mask-front-content mask-front-content-31">
                <p>
                    Ideal M1-Prodrug Enzyme System

                </p>
            </div>
            <div class="mask-front-content mask-front-content-32">
                <p>
                    Drug Screening

                </p>
            </div>
        </div>
        <div class="mask mask-3-box">
            <!-- <div class="mask-3 m30"></div> -->
            <div class="mask-3 m31"></div>
            <div class="mask-3 m32"></div>

        </div>
        <div class="rich-content-box">
            <!-- <div class="rich-content rich-content-30">
                <img src="https://2019.igem.org/wiki/images/thumb/2/2d/T--SYSU-Medicine--future_perspectives_1.png/1600px-T--SYSU-Medicine--future_perspectives_1.png"
                    class="img-fp-0">
                <p>
                    &nbsp&nbsp&nbsp&nbspIn our study, we expand the anti-cancer spectrum of oncolytic virus M1 by
                    directed evolution. We
                    plan to explore the characteristics of each mutation site and standardize it as parts, so that
                    we
                    could be combined different mutation according to different purposes. Taking advantages of each
                    mutations, we could obtain the boarder anti-cancer spectrum M1 virus. Further, we can enhance
                    other
                    oncolytic alphavirus through the same method. In addition, through in combination with
                    Actinomycin
                    D, M1 has a great lethality to insensitive cancer cells. M1 armed with nitroreductase could be
                    used
                    to combine with other chemotherapy drugs.
                </p>
            </div> -->
            <div class="rich-content rich-content-31">

                <p><b class="b_have_border">Ideal M1-Prodrug Enzyme System</b><br>
                    As described in the experimental results, we first verified the significant effect of prodrug enzyme
                    system and M1 combination on the reduction of side effects of chemotherapy drugs with CB1954.
                    Furthermore, we verified that the chemotherapy drug actinomycin D can in turn promote M1 infection
                    on a variety of tumor cells. Therefore, if we can combine the advantages of the two, this would be
                    an ideal M1 prodrug enzyme system. To this end, we designed the prodrug structure of actinomycin D
                    (see design for details) and screened a variety of drugs with similar mechanism of action to
                    actinomycin D. We plan to carry out further experimental verification soon.
                </p>
                <img src="https://2019.igem.org/wiki/images/thumb/6/60/T--SYSU-Medicine--approach_1.png/1600px-T--SYSU-Medicine--approach_1.png"
                    class="img-fp-1">
            </div>
            <div class="rich-content rich-content-32">
                <img src="https://2019.igem.org/wiki/images/thumb/c/c9/T--SYSU-Medicine--future_perspectives_3.png/1600px-T--SYSU-Medicine--future_perspectives_3.png"
                    class="img-fp-2">
                <p><b class="b_have_border">Drug Screening</b><br>
                    In our project, we proved that the efficacy of M1-directed nitroreductase system in combination with
                    CB1954, which made it possible to use M1 vector to combine with other chemotherapy drugs. Previous
                    studies have shown that there are many side effects of chemotherapy, such as myelosuppression,
                    gastrointestinal reactions, liver function impairment etc. So it is necessary to improve the target
                    of these drugs. Therefore, we plan to screen for more effective chemotherapy drugs, such as
                    Etoposide, Daunorubicin etc., to combine with M1-directed enzyme prodrug system.


                </p>
            </div>
        </div>
    </div>
    <div class="sub-content" id="content-4">
        <div class="switch"></div>
        <div class="mask-front-content-box">
            <!-- <div class="mask-front-content mask-front-content-30">
                    <p>Building better oncolytic virus
                    </p>
                </div> -->
            <div class="mask-front-content mask-front-content-41">
                <p>
                    Directed Evolution

                </p>
            </div>
            <div class="mask-front-content mask-front-content-42">
                <p>
                    Clinical Application

                </p>
            </div>
        </div>
        <div class="mask mask-4-box">
            <!-- <div class="mask-3 m30"></div> -->
            <div class="mask-4 m41"></div>
            <div class="mask-4 m42"></div>

        </div>
        <div class="rich-content-box">
            <!-- <div class="rich-content rich-content-30">
                    <img src="https://2019.igem.org/wiki/images/thumb/2/2d/T--SYSU-Medicine--future_perspectives_1.png/1600px-T--SYSU-Medicine--future_perspectives_1.png"
                        class="img-fp-0">
                    <p>
                        &nbsp&nbsp&nbsp&nbspIn our study, we expand the anti-cancer spectrum of oncolytic virus M1 by
                        directed evolution. We
                        plan to explore the characteristics of each mutation site and standardize it as parts, so that
                        we
                        could be combined different mutation according to different purposes. Taking advantages of each
                        mutations, we could obtain the boarder anti-cancer spectrum M1 virus. Further, we can enhance
                        other
                        oncolytic alphavirus through the same method. In addition, through in combination with
                        Actinomycin
                        D, M1 has a great lethality to insensitive cancer cells. M1 armed with nitroreductase could be
                        used
                        to combine with other chemotherapy drugs.
                    </p>
                </div> -->
            <div class="rich-content rich-content-41">

                <p><b class="b_have_border">Directed Evolution</b><br>
                    In the experiment, we observed that the expression level of nitroreductase in the cell itself would
                    affect the transformation of prodrug, and at the same time, actinomycin D played a role in promoting
                    M1 virus infection. It is reasonable to speculate that this feature can be used to exert selective
                    pressure on the evolution of M1, and to give drugs to tumor cells with low expression level of
                    nitroreductase for targeted evolutionary screening of M1.
                </p>
                <img src="https://2019.igem.org/wiki/images/c/cf/T--SYSU-Medicine--des_f1.png" class="img-fp-1">
            </div>
            <div class="rich-content rich-content-42">
                <img src="https://2019.igem.org/wiki/images/c/c0/T--SYSU-Medicine--des_f2.png" class="img-fp-2">
                <p><b class="b_have_border">Clinical Application</b><br>
                    Virus-directed enzyme prodrug therapy is one of the major strategy of the targeted delivery of
                    cytotoxic compounds to tumor tissue, increasing cytotoxicity of bioreductive agents [24]. The vitro
                    experiment of the prodrug system has demonstrated the effectiveness of the combined therapy. The
                    5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954) is a mature anticancer prodrug that is efficiently
                    reduced by nitroreductase, requiring reduction to the 2-and 4-hydroxylamines to be cytotoxic CB1954.
                    M1 virus has good target and safety, which can achieve the targeting of CB1954. With the merit of
                    increasing effective killing of tumor cells and being less damage to the surrounding normal tissues,
                    this combined therapy is possible to be applied to medical and clinical treatment in the future.
                    Although M1-directed nitroreductase therapy have shown effective bystander effect of CB1954 in
                    vitro, the study to prove this system in vivo has not been done. Therefore, more researches are
                    needed to improve this therapy.


                </p>
            </div>
        </div>
    </div>
    <div class="reference-box">
        <div class="title-box-new-des title-4">
            <div class="title-box-mask"></div>
            <div class="title-box-title">
                <h1 class="reference-title">REFERENCE</h1>
            </div>
        </div>
        <div class="reference-content">
            <p>[1] Hu J, Cai XF, Yan G. Alphavirus M1 induces apoptosis of malignant glioma cells via downregulation and
                nucleolar translocation of p21WAF1/CIP1 protein. Cell Cycle. 2009;8(20):3328–3339.</p>
            <p>[2] Fukunaga Y, Kumanomido T, Kamada M. Getah virus as an equine pathogen. Vet Clin North Am Equine
                Pract. 2000;16(3):605–617.</p>
            <p>[3] Lin, Y., et al., Identification and characterization of alphavirus M1 as a selective oncolytic virus
                targeting ZAP-defective human cancers. Proc Natl Acad Sci U S A, 2014. 111(42): p. E4504-12.</p>
            <p>[4] Vekshin, N. Actinomycins Like Anti-Cancer Photo-Sensitizers. Journal of Fluorescence, 2011;21(4),
                1417–1420. doi:10.1007/s10895-010-0825-8.</p>
            <p>[5] Vanneman M, Dranoff G. Combining immunotherapy and targeted therapies in cancer treatment. Nat Rev
                Cancer. 2012;12(4):237–251. Published 2012 Mar 22. </p>
            <p>
                [6] Gotwals, P., Cameron, S., Cipolletta, D., Cremasco, V., Crystal, A., Hewes, B., … Dranoff, G.
                Prospects for combining targeted and conventional cancer therapy with immunotherapy. Nat Rev Cancer.
                2017;17(5), 286–301. </p>
            <p>[7] Kaufman, H. L., Kohlhapp, F. J., & Zloza, A. Oncolytic viruses: a new class of immunotherapy drugs.
                Nature Reviews Drug Discovery. 2015;14(9), 642-662. </p>
            <p> [8] Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).
            </p>
            <p>[9] Pikor, L. A., Bell, J. C., & Diallo, J.-S. Oncolytic Viruses: Exploiting Cancer’s Deal with the
                Devil. Trends in Cancer. 2015;1(4), 266–277. doi:10.1016/j.trecan.2015.10.004 </p>
            <p>[10] Twumasi-Boateng, K., Pettigrew, J. L., Kwok, Y. Y. E., Bell, J. C., & Nelson, B. H. (2018).
                Oncolytic viruses as engineering platforms for combination immunotherapy. Nature Reviews Cancer, 18(7),
                419–432. </p>
            <p> [11] US Food and Drug Administration. FDA approves first-of-its-kind product for the treatment of
                melanoma. Published October 27, 2015. Accessed December 6, 2015.</p>
            <p>[12] Russell SJ, Peng KW, Bell JC. Oncolytic virotherapy. Nat Biotechnol. 2012;30(7):658–670. Published
                2012 Jul 10. </p>
            <p>[13] Wen, J.S., et al., Genomic analysis of a Chinese isolate of Getah-like virus and its phylogenetic
                relationship with other Alphaviruses. Virus Genes, 2007. 35(3): p. 597-603.</p>
            <p>[14] Li, Y.Y., et al., From discovery to spread: The evolution and phylogeny of Getah virus. Infect Genet
                Evol, 2017. 55: p. 48-55.</p>
            <p> [15] Wang, H.Q., et al., [Isolation and identification of arboviruses in Hebei Province]. Zhonghua Shi
                Yan He Lin Chuang Bing Du Xue Za Zhi, 2006. 20(1): p. 52-5.</p>
            <p> [16] Y. Lin, H. Zhang, J. Lianget al. Identification and characterization of alphavirus M1 as a
                selective oncolytic virus targeting ZAP-defective human cancers. Proceedings of the National Academy of
                Sciences of the United States of America，2014;111（42）：E4504-E4512.</p>
            <p>[17] J. Liang, L. Guo, K. Liet al. Inhibition of the mevalonate pathway enhances cancer cell oncolysis
                mediated by M1 virus. Nature Communications，2018;9（1）</p>
            <p> [18] K. Li, C. Hu, F. Xinget al. Deficiency of the IRE1α-Autophagy Axis Enhances the Antitumor Effects
                of the Oncolytic Virus M1. J Virol，2018;92（6）</p>
            <p>[19] Grimley, P.M., et al., Specific membranous structures associated with the replication of group A
                arboviruses. J Virol, 1972. 10(3): p. 492-503.</p>
            <p>[20] Douglas Hanahan, Robert A Weinberg, The Hallmarks of Cancer, Cell, Volume 100, Issue 1, 2000, Pages
                57-70, ISSN 0092-8674.</p>
            <p>[21] GIFFORD, G.E. and E. HELLER, EFFECT OF ACTINOMYCIN D ON INTERFERON PRODUCTION BY 'ACTIVE' AND
                'INACTIVE' CHIKUNGUNYA VIRUS IN CHICK CELLS. Nature, 1963. 200: p. 50-1.</p>
            <p> [22] Carter, M.F., et al., Effects of actinomycin D and ultraviolet and ionizing radiation on Pichinde
                virus. J Virol, 1973. 12(1): p. 33-8.</p>
            <p>
                [23] Burlandy, F.M. and M.A. Rebello, Inhibition of Mayaro virus replication by prostaglandin A(1) in
                Vero cells. Intervirology, 2001. 44(6): p. 344-9.
            </p>
            <p>[24] Szewczuk, M., et al., Virus-directed enzyme prodrug therapy and the assessment of the cytotoxic
                impact of some benzimidazole derivatives. Tumour Biol, 2017. 39(7): p. 1010428317713675.</p>
















        </div>
    </div>
    <div class="space" style="height: 30vw;"></div>
</body>
<script>
    $(function () { $(".navigation").css("width", window.innerWidth); });
    // all in one

    // $(function () {
    //     $(".piano-subpage-key").addClass("stop-animation");
    //     $(".piano-subpage-key").addClass("animation");
    //     $(".key-kernel").addClass("animation");
    // });
    // var piano_flag = [];
    // $(function () {
    //     $(".sub-content").each(function () {
    //         piano_flag.push(1);
    //         $(".test").text(piano_flag);
    //     });
    // });

    // $(document).scroll(function () {
    //     debug = []
    //     playing_flag = 1;
    //     $(".sub-content").each(function (i, each_0) {
    //         var content_top = $(each_0).offset().top - $(window).scrollTop();
    //         var content_bottom = content_top + $(each_0).outerHeight();
    //         debug.push(content_bottom);
    //         var judge = window.innerHeight / 3 * 2;
    //         $(".test").text(piano_flag);
    //         if (content_top < judge) {
    //             if (playing_flag) {
    //                 piano_flag[i] = 0;
    //                 var key_id = $(each_0).attr("id");
    //                 key_id += "-key";//找到钢琴键
    //                 playing_flag = 1;
    //                 $(document.getElementById(key_id)).animate({
    //                     width: "12vw",
    //                     height: "2vh"
    //                 }, 200,function(){
    //                     playing_flag = 1;
    //                 });//钢琴放大
    //             }
    //             //    $(document.getElementById(key_id)).children().animate({background-color: "rgb(255,55,68)"})
    //         }
    //         if (content_bottom < judge) {

    //             piano_flag[i] = 1;
    //             var key_id = $(each_0).attr("id");
    //             key_id += "-key";//找到钢琴键
    //             $(document.getElementById(key_id)).animate({
    //                 width: "8vw",
    //                 height: "1vh"
    //             }, 200)//钢琴缩小
    //             //    $(document.getElementById(key_id)).children().animate({background-color: "rgb(255,55,68)"})
    //         }
    //         console.log(debug);
    //     }

    //     );
    //     // var scrollBox = $(document);
    //     //     //调用throttle函数，传入相应的方法和规定的时间;
    //     //     var thro = throttle(throFun,300);
    //     //     //触发事件;
    //     //     scrollBox.on('scroll' , function(){
    //     //         //调用执行函数;
    //     //         thro();
    //     //     })

    //     //     // 封装函数;    
    //     //     function throttle(method,time){
    //     //         var timer = null;
    //     //         var startTime = new Date();
    //     //         return function(){
    //     //             var context = this;
    //     //             var endTime = new Date();
    //     //             var resTime = endTime - startTime;
    //     //             //判断大于等于我们给的时间采取执行函数;
    //     //             if(resTime >= time){
    //     //                 method.call(context);
    //     //                 //执行完函数之后重置初始时间，等于最后一次触发的时间
    //     //                 startTime = endTime;
    //     //             }
    //     //         }
    //     //     }
    //     //     function throFun(){
    //     //         $(".sub-content").each(function(i,each_0){
    //     //             var content_top = $(each_0).offset().top - $(window).scrollTop();
    //     //             var content_bottom = content_top + $(each_0).outerHeight();

    //     //             var judge = window.innerHeight/3*2;
    //     //             $(".test").text(content_bottom-judge);
    //     //             if (content_top<judge){
    //     //                 if (piano_flag){
    //     //                     piano_flag = 0;
    //     //                     var key_id =  $(each_0).attr("id");
    //     //                     key_id += "-key";//找到钢琴键
    //     //                     $(document.getElementById(key_id)).animate({width:"12vw",
    //     //                      height: "2vh"},200);//钢琴放大
    //     //                 }    
    //     //             //    $(document.getElementById(key_id)).children().animate({background-color: "rgb(255,55,68)"})
    //     //             }
    //     //             if (content_bottom<judge){
    //     //                 // 
    //     //                 piano_flag = 1;
    //     //                 var key_id =  $(each_0).attr("id");
    //     //                 key_id += "-key";//找到钢琴键
    //     //                 $(document.getElementById(key_id)).animate({width:"8vw",
    //     //                  height: "1vh"},200)//钢琴缩小
    //     //              //    $(document.getElementById(key_id)).children().animate({background-color: "rgb(255,55,68)"})
    //     //              }

    //     //         });
    //     //     }



    // });

    $(function () {
        $("#content-0").css("height", "30vw");
    });
    var hover_speed = 300;
    //content-0 悬停+点击
    $(function () {
        //悬停

        $("#content-0 .switch").hover(function () {

            var $mask = $($(this).nextAll(".mask"));
            if ($mask.hasClass("hover_flag")) { } else {
                $mask.addClass("hover_flag");
                var $mask = $($(this).nextAll(".mask"));//获取遮罩层
                $mask.children().each(function () {
                    var fuck = $(this).width() * 0.9;
                    $(this).animate({ width: "42vw" }, hover_speed, "swing");
                    $(this).animate({ width: "45vw" }, hover_speed, "swing", function () {
                        $mask.removeClass("hover_flag");
                    });

                })

            }


        }, function () {
            // var $mask = $($(this).nextAll(".mask"));
            // if ($mask.hasClass("open-flag")) { } else {
            //     var $mask = $($(this).nextAll(".mask"));//获取遮罩层
            //     $mask.children().each(function () {
            //         var fuck = $(this).width() / 0.9;
            //         $(this).animate({ width: "45vw" }, 150, "swing");
            //     })
            // }
        });
        //点击
        $("#content-0 .switch").click(function () {
            // var $mask = $($(this).nextAll(".mask"));//获取遮罩层
            // if ($mask.hasClass("open-flag")) {
            //     $mask.removeClass("open-flag");
            //     $mask.children().each(function () {
            //         $(this).animate({ opacity: "100" }, 1);
            //         $(this).animate({ width: $(".mask-0-box").width()/2 }, 1000);

            //     });
            //     $($(this).nextAll(".mask-front-content-box")).animate({ opacity: "100" }, 1000,);
            // } else {
            //     $("#content-0").animate({ height: "75vw" }, 750, function () {
            //         var $mask = $($("#content-0 .switch").nextAll(".mask"));
            //         // $("#content-0").find(".need-scale-rich-0").removeClass("need-scale-rich-0");
            //         $(".rich-content-box-shadow").css("display","none");
            //         $mask.children().each(function () {
            //             $(this).attr("old-width", $(this).width());
            //             $(this).animate({ width: "0" }, 750, "swing");
            //             $(this).animate({ opacity: "0" }, 1, "swing");
            //         });


            //     });
            //     $("#content-0").find(".need-scale-rich-0").animate({opacity: "100"},1500);
            //     // $("#content-0").find(".need-scale-rich-0").animate({transform: "scaleY(1)"},750);
            //     $mask.addClass("open-flag");
            //     hover_flag = 0;
            //     $($(this).nextAll(".mask-front-content-box")).animate({ opacity: "0" }, 1000);
            // }
            $("#content-0").animate({ height: "75vw" }, 750, function () {
                var $mask = $($("#content-0 .switch").nextAll(".mask"));
                // $("#content-0").find(".need-scale-rich-0").removeClass("need-scale-rich-0");
                $(".rich-content-box-shadow").css("display", "none");
                $mask.children().each(function () {
                    $(this).attr("old-width", $(this).width());
                    $(this).animate({ width: "0" }, 750, "swing");
                    $(this).animate({ opacity: "0" }, 1, "swing", function () {
                        $(".mask-0-box").css({ "width": "0", "height": "0" });
                    });
                });


            });
            $("#content-0").find(".need-scale-rich-0").animate({ opacity: "100" }, 1500);
            // $("#content-0").find(".need-scale-rich-0").animate({transform: "scaleY(1)"},750);

            hover_flag = 0;
            $($(this).nextAll(".mask-front-content-box")).animate({ opacity: "0" }, 1000, function () {
                $(this).css({ "width": "0", "height": "0" });
            });
            $("#content-0 .switch").css({ "width": "0", "height": "0" });

        });
        //

    });



    //content-1 悬停+点击
    $(function () {
        //悬停

        $("#content-1 .switch").hover(function () {
            var $mask = $($(this).nextAll(".mask"));
            if ($mask.hasClass("hover_flag")) { } else {
                $mask.addClass("hover_flag");
                var $mask = $($(this).nextAll(".mask"));//获取遮罩层
                $mask.find(".mask-1").each(function () {

                    $(this).animate({ width: "43vw", height: "15vw" }, hover_speed, "swing");
                    $(this).animate({ width: "45vw", height: "18vw" }, hover_speed, "swing", function () {
                        $mask.removeClass("hover_flag");
                    });
                    // $(this).animate({ height: "13vw" }, hover_speed, "swing");

                })
            }
        }, function () {
            // var $mask = $($(this).nextAll(".mask"));
            // if ($mask.hasClass("open-flag")) { } else {
            //     var $mask = $($(this).nextAll(".mask"));//获取遮罩层
            //     $mask.find(".mask-1").each(function () {

            //         $(this).animate({ width: "45vw",height: "18vw" }, hover_speed, "swing");
            //         // $(this).animate({  }, hover_speed, "swing");
            //     })
            // }
        });
        //点击
        $("#content-1 .switch").click(function () {
            // speed = 700;
            // var $mask = $($(this).nextAll(".mask"));//获取遮罩层
            // if ($mask.hasClass("open-flag")) {
            //     $mask.removeClass("open-flag");
            //     $mask.find(".mask-1").each(function () {
            //         $(this).animate({ opacity: "100" }, 1, "swing");
            //         $(this).animate({ width: $(".mask-1-box").width()/2, height: $(".mask-1-box").height()/2 }, speed, "swing");


            //     });
            //     $($(this).nextAll(".mask-front-content-box")).animate({ opacity: "100" }, speed);
            // } else {
            //     $mask.find(".mask-1").each(function () {
            //         $(this).attr("old-width", $(this).width());
            //         $(this).attr("old-height", $(this).height());
            //         $(this).animate({ width: "0", height: "0" }, speed, "swing");
            //         $(this).animate({ opacity: "0" }, 1, "swing");

            //     });
            //     $mask.addClass("open-flag");
            //     hover_flag = 0;
            //     $($(this).nextAll(".mask-front-content-box")).animate({ opacity: "0" }, speed);
            // }
            speed = 700;
            var $mask = $($(this).nextAll(".mask"));//获取遮罩层
            $mask.find(".mask-1").each(function () {
                $(this).attr("old-width", $(this).width());
                $(this).attr("old-height", $(this).height());
                $(this).animate({ width: "0", height: "0" }, speed, "swing");
                $(this).animate({ opacity: "0" }, 1, "swing", function () {
                    $(".mask-1-box").css({ "width": "0", "height": "0" });
                });

            });
            $mask.addClass("open-flag");
            hover_flag = 0;
            $($(this).nextAll(".mask-front-content-box")).animate({ opacity: "0" }, speed, function () {
                $(this).css({ "width": "0", "height": "0" });
            });
            $("#content-1 .switch").css({ "width": "0", "height": "0" });

        })
    });


    //content-2 悬停+点击
    $(function () {
        //悬停

        $("#content-2 .switch").hover(function () {
            var $mask = $($(this).nextAll(".mask"));
            if ($mask.hasClass("hover_flag")) { } else {
                $mask.addClass("hover_flag");
                var $mask = $($(this).nextAll(".mask"));//获取遮罩层
                $mask.children().each(function () {

                    $(this).animate({ width: "40vw" }, hover_speed, "swing");
                    $(this).animate({ width: "45vw" }, hover_speed, "swing", function () {
                        $mask.removeClass("hover_flag");
                    });
                })
            }

        }, function () {
            // var $mask = $($(this).nextAll(".mask"));
            // if ($mask.hasClass("open-flag")) { } else {
            //     var $mask = $($(this).nextAll(".mask"));//获取遮罩层
            //     $mask.children().each(function () {

            //         $(this).animate({ width: "45vw" }, hover_speed, "swing");
            //     })
            // }
        });
        //点击
        // $("#content-2 .switch").click(function () {
        //     speed = 700;
        //     var $mask = $($(this).nextAll(".mask"));//获取遮罩层
        //     if ($mask.hasClass("open-flag")) {
        //         $mask.removeClass("open-flag");
        //         $mask.children().each(function () {
        //             $(this).animate({ opacity: "100" }, 1, "swing");
        //             $(this).animate({ width: $(".mask-2-box").width()/2 }, speed, "swing");

        //         });
        //         $($(this).nextAll(".mask-front-content-box")).animate({ opacity: "100" }, speed);
        //     } else {
        //         $mask.children().each(function () {
        //             $(this).attr("old-width", $(this).width());
        //             $(this).animate({ width: "0" }, speed, "swing");
        //             $(this).animate({ opacity: "0" }, 1, "swing");

        //         });
        //         $mask.addClass("open-flag");
        //         hover_flag = 0;
        //         $($(this).nextAll(".mask-front-content-box")).animate({ opacity: "0" }, speed);
        //     }

        // })
        $("#content-2 .switch").click(function () {
            speed = 700;
            var $mask = $($(this).nextAll(".mask"));//获取遮罩层
            $mask.children().each(function () {
                $(this).attr("old-width", $(this).width());
                $(this).animate({ width: "0" }, speed, "swing");
                $(this).animate({ opacity: "0" }, 1, "swing", function () {
                    $(".mask-2-box").css({ "width": "0", "height": "0" });
                });

            });
            $mask.addClass("open-flag");
            hover_flag = 0;
            $($(this).nextAll(".mask-front-content-box")).animate({ opacity: "0" }, speed, function () {
                $(this).css({ "width": "0", "height": "0" });
            });
            $("#content-2 .switch").css({ "width": "0", "height": "0" });

        })
    });

    //content-3 悬停+点击
    $(function () {
        //悬停

        $("#content-3 .switch").hover(function () {

            var $mask = $($(this).nextAll(".mask"));
            if ($mask.hasClass("hover_flag")) { } else {
                $mask.addClass("hover_flag");
                var $mask = $($(this).nextAll(".mask"));//获取遮罩层
                $mask.children().each(function () {

                    $(this).animate({ width: "80vw" }, hover_speed, "swing");
                    $(this).animate({ width: "90vw" }, hover_speed, "swing", function () {
                        $mask.removeClass("hover_flag");
                    });
                })
            }

        }, function () {
            // var $mask = $($(this).nextAll(".mask"));
            // if ($mask.hasClass("open-flag")) { } else {
            //     var $mask = $($(this).nextAll(".mask"));//获取遮罩层
            //     $mask.children().each(function () {

            //         $(this).animate({ width: "90vw" }, hover_speed, "swing");
            //     })
            // }
        });
        //点击
        // $("#content-3 .switch").click(function () {
        //     speed = 700;
        //     var $mask = $($(this).nextAll(".mask"));//获取遮罩层
        //     if ($mask.hasClass("open-flag")) {
        //         $mask.removeClass("open-flag");
        //         $mask.children().each(function () {
        //             $(this).animate({ opacity: "100" }, 1, "swing");
        //             $(this).animate({ width: $(".mask-3-box").width() }, speed, "swing");

        //         });
        //         $($(this).nextAll(".mask-front-content-box")).animate({ opacity: "100" }, speed);
        //     } else {
        //         $mask.children().each(function () {
        //             $(this).attr("old-width", $(this).width());
        //             $(this).animate({ width: "0" }, speed, "swing");
        //             $(this).animate({ opacity: "0" }, 1, "swing");

        //         });
        //         $mask.addClass("open-flag");
        //         hover_flag = 0;
        //         $($(this).nextAll(".mask-front-content-box")).animate({ opacity: "0" }, speed);
        //     }

        // })
        $("#content-3 .switch").click(function () {
            speed = 700;
            var $mask = $($(this).nextAll(".mask"));//获取遮罩层
            $mask.children().each(function () {
                $(this).attr("old-width", $(this).width());
                $(this).animate({ width: "0" }, speed, "swing");
                $(this).animate({ opacity: "0" }, 1, "swing", function () {
                    $(".mask-3-box").css({ "width": "0", "height": "0" });
                });

            });
            $mask.addClass("open-flag");
            hover_flag = 0;
            $($(this).nextAll(".mask-front-content-box")).animate({ opacity: "0" }, speed, function () {
                $(this).css({ "width": "0", "height": "0" });
            });
            $("#content-3 .switch").css({ "width": "0", "height": "0" });
        })
    });

    //content-3 悬停+点击
    $(function () {
        //悬停

        $("#content-4 .switch").hover(function () {

            var $mask = $($(this).nextAll(".mask"));
            if ($mask.hasClass("hover_flag")) { } else {
                $mask.addClass("hover_flag");
                var $mask = $($(this).nextAll(".mask"));//获取遮罩层
                $mask.children().each(function () {

                    $(this).animate({ width: "80vw" }, hover_speed, "swing");
                    $(this).animate({ width: "90vw" }, hover_speed, "swing", function () {
                        $mask.removeClass("hover_flag");
                    });
                })
            }

        }, function () {
            // var $mask = $($(this).nextAll(".mask"));
            // if ($mask.hasClass("open-flag")) { } else {
            //     var $mask = $($(this).nextAll(".mask"));//获取遮罩层
            //     $mask.children().each(function () {

            //         $(this).animate({ width: "90vw" }, hover_speed, "swing");
            //     })
            // }
        });
        //点击
        // $("#content-3 .switch").click(function () {
        //     speed = 700;
        //     var $mask = $($(this).nextAll(".mask"));//获取遮罩层
        //     if ($mask.hasClass("open-flag")) {
        //         $mask.removeClass("open-flag");
        //         $mask.children().each(function () {
        //             $(this).animate({ opacity: "100" }, 1, "swing");
        //             $(this).animate({ width: $(".mask-3-box").width() }, speed, "swing");

        //         });
        //         $($(this).nextAll(".mask-front-content-box")).animate({ opacity: "100" }, speed);
        //     } else {
        //         $mask.children().each(function () {
        //             $(this).attr("old-width", $(this).width());
        //             $(this).animate({ width: "0" }, speed, "swing");
        //             $(this).animate({ opacity: "0" }, 1, "swing");

        //         });
        //         $mask.addClass("open-flag");
        //         hover_flag = 0;
        //         $($(this).nextAll(".mask-front-content-box")).animate({ opacity: "0" }, speed);
        //     }

        // })
        $("#content-4 .switch").click(function () {
            speed = 700;
            var $mask = $($(this).nextAll(".mask"));//获取遮罩层
            $mask.children().each(function () {
                $(this).attr("old-width", $(this).width());
                $(this).animate({ width: "0" }, speed, "swing");
                $(this).animate({ opacity: "0" }, 1, "swing", function () {
                    $(".mask-4-box").css({ "width": "0", "height": "0" });
                });

            });
            $mask.addClass("open-flag");
            hover_flag = 0;
            $($(this).nextAll(".mask-front-content-box")).animate({ opacity: "0" }, speed, function () {
                $(this).css({ "width": "0", "height": "0" });
            });
            $("#content-4 .switch").css({ "width": "0", "height": "0" });
        })
    });







    // title 出现  后期吧subpage和homepage合并
    $(document).ready(function () {
        speed = 250
        $(".title-box-new-des").each(function (titlebox_i, title_box) {
            var last = $(title_box).offset().top - $(window).scrollTop();
            var viewheight = window.innerHeight / 5 * 3;
            if (last < viewheight) {
                if ($(title_box).hasClass("played")) { } else {
                    $(title_box).addClass("played");

                    $(title_box).children(".title-box-mask").addClass("title-box-mask-left");
                    $(title_box).children(".title-box-mask").animate({ width: $(title_box).width() }, speed, "swing", function () {
                        $(title_box).children(".title-box-mask").removeClass("title-box-mask-left");
                        $(title_box).children(".title-box-mask").addClass("title-box-mask-right");
                        $(title_box).children(".title-box-title").animate({ opacity: "100" }, speed / 2);
                    });
                    $(title_box).children(".title-box-mask").animate({ width: "0" }, speed, "swing");
                }


            }
        });
    })
    $(document).scroll(function () {
        speed = 250
        $(".title-box-new-des").each(function (titlebox_i, title_box) {
            var last = $(title_box).offset().top - $(window).scrollTop();
            var viewheight = window.innerHeight / 5 * 3;
            if (last < viewheight) {
                if ($(title_box).hasClass("played")) { } else {
                    $(title_box).addClass("played");

                    $(title_box).children(".title-box-mask").addClass("title-box-mask-left");
                    $(title_box).children(".title-box-mask").animate({ width: $(title_box).width() }, speed, "swing", function () {
                        $(title_box).children(".title-box-mask").removeClass("title-box-mask-left");
                        $(title_box).children(".title-box-mask").addClass("title-box-mask-right");
                        $(title_box).children(".title-box-title").animate({ opacity: "100" }, speed / 2);
                    });
                    $(title_box).children(".title-box-mask").animate({ width: "0" }, speed, "swing");
                }


            }
        });
    })
    //all in one end
</script>

</html>